BioXell is a listed biopharmaceutical company focused on the discovery and development of drugs that exploit novel mechanisms of action. Following the conclusion of its Vitamin D3 related R&D activities BioXell has been looking into a number of strategic options in line with the demands of its shareholders. BioXell was founded in 2002 as a spin-out from Roche. In June 2006, BioXell listed its shares on the main segment of the SIX Swiss Exchange. The company is located in Milan, Italy.
| Website | http://www.bioxell.com |
| Ticker | SWX:BXLN |
| Revenue | $14 million |
| Employees | View employees |
| Founded | 2002 |
| Address | PO Box 588, Nutley, New Jersey 07110, US |
| Phone | +39 02 210 4951 |
| Industry | Manufacturing General, Association, Manufacturing, Biotechnology, Science and Engineering, Education, Medical, Health Care |
| SIC | SIC Code 283 Companies, SIC Code 2834 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular BioXell SpA employee's phone or email?
BioXell SpA Questions
The BioXell SpA annual revenue was $14 million in 2026.
BioXell SpA is based in Nutley, New Jersey.
The NAICS codes for BioXell SpA are [32541, 32, 325, 3254].
The SIC codes for BioXell SpA are [283, 2834, 28].
